The owner of Priceline pharmacies is forecasting profit growth as sales and store numbers continue to rise.
Australian Pharmaceutical Industries expects to make an underlying net profit of at least $24 million in the six months to February, up from $21.3 million in the same period a year ago.
Chief executive Stephen Roche told the company's annual general meeting that overall sales are up eight per cent since the end of August, and like-for-like sales are up two per cent.
He expects 20 new stores to be opened before the end of August 2016, taking total stores to 440.
Share
